Andreas Halvorsen portfolio · Q4 2025
Viking Global Investors LP · CIK 0001103804 ·13F filings on SEC EDGAR
In Q4 2025, Viking Global Investors LP reported 76 positions worth $37.7B. Its largest holding was MSFT at 4.1% of the portfolio, and the top 10 made up 35%. This is the earliest quarter available here, so changes are not shown.
Portfolio map
Each box is a position sized by its value. There is no previous quarter here to compare changes. The smallest 36 positions are grouped as one box.
Holdings
Click a holding to see its price chart with the quarters the investor bought or sold.
| Name | Weight | Avg. cost (est.) | Latest price | Gain/loss | Value |
|---|---|---|---|---|---|
MSFT MICROSOFT CORP | 4.13% | $509.54 | $512.90 | +0.7% | $1.7B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PNC PNC FINANCIAL SERVICES GROUP | 4.04% | $196.60 | $222.26 | +13.1% | $1.6B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TSM TAIWAN SEMICONDUCTOR-SP ADR | 3.96% | $214.37 | $456.19 | +112.8% | $2.2B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
V VISA INC-CLASS A SHARES | 3.71% | $316.90 | $359.33 | +13.4% | $1.4B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
SCHW SCHWAB (CHARLES) CORP | 3.68% | $74.60 | $97.74 | +31.0% | $1.4B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
DIS WALT DISNEY CO/THE | 3.38% | $119.42 | $104.90 | -12.2% | $1.2B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
APD AIR PRODUCTS & CHEMICALS INC | 3.14% | $270.93 | $278.23 | +2.7% | $1.3B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
MCD MCDONALD'S CORP | 2.94% | $300.31 | $230.94 | -23.1% | $835.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BBIO BRIDGEBIO PHARMA INC | 2.92% | $26.97 | $65.80 | +144.0% | $947.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
FTV FORTIVE CORP | 2.82% | $64.19 | $54.81 | -14.6% | $1.1B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
SHW SHERWIN-WILLIAMS CO/THE | 2.73% | $345.46 | $323.27 | -6.4% | $1B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BA BOEING CO/THE | 2.28% | $187.92 | $186.05 | -1.0% | $735.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
GOOGL ALPHABET INC-CL A | 2.21% | $313.00 | $344.08 | +9.9% | $917.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AMD ADVANCED MICRO DEVICES | 2.13% | $152.70 | $611.76 | +300.6% | $2.3B |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ICE INTERCONTINENTAL EXCHANGE IN | 2.06% | $161.96 | $152.03 | -6.1% | $730.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TSLA TESLA INC | 2.03% | $350.68 | $354.81 | +1.2% | $603.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TMUS T-MOBILE US INC | 2.02% | $228.65 | $163.08 | -28.7% | $612.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AMZN AMAZON.COM INC | 1.92% | $230.82 | $249.15 | +7.9% | $779M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
COF CAPITAL ONE FINANCIAL CORP | 1.90% | $191.93 | $193.07 | +0.6% | $570M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
JCI JOHNSON CONTROLS INTERNATION | 1.88% | $109.03 | $148.65 | +36.3% | $879.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
DKNG DRAFTKINGS INC-CL A | 1.75% | $36.77 | $19.00 | -48.3% | $363.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
JPM JPMORGAN CHASE & CO | 1.63% | $265.87 | $330.83 | +24.4% | $630.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ROST ROSS STORES INC | 1.51% | $152.07 | $233.40 | +53.5% | $739.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
GM GENERAL MOTORS CO | 1.47% | $49.25 | $77.00 | +56.3% | $524.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
MAA MID-AMERICA APARTMENT COMM | 1.43% | $139.47 | $117.74 | -15.6% | $456.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CPT CAMDEN PROPERTY TRUST | 1.39% | $107.52 | $96.73 | -10.0% | $460.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
DKS DICK'S SPORTING GOODS INC | 1.35% | $197.97 | $201.44 | +1.8% | $518.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CLS CELESTICA INC | 1.33% | $246.38 | $361.43 | +46.7% | $614.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CSX CSX CORP | 1.33% | $32.49 | $46.51 | +43.2% | $642.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ADPT ADAPTIVE BIOTECHNOLOGIES | 1.29% | $48.30 | $28.90 | -40.2% | $866.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
SE SEA LTD-ADR | 1.24% | $129.99 | $97.36 | -25.1% | $357.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
HCA HCA HEALTHCARE INC | 1.24% | $328.05 | $426.74 | +30.1% | $426.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TMO THERMO FISHER SCIENTIFIC INC | 1.22% | $579.45 | $675.05 | +16.5% | $535.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
RRX REGAL REXNORD CORP | 1.20% | $130.29 | $155.11 | +19.1% | $500.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CVNA CARVANA CO | 1.19% | $285.93 | $312.70 | +9.4% | $331.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CHWY CHEWY INC - CLASS A | 1.19% | $36.05 | $18.20 | -49.5% | $246.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
APG API GROUP CORP | 1.17% | $8.27 | $38.60 | +366.9% | $445.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
STLA STELLANTIS NV | 1.15% | $10.89 | $4.39 | -59.7% | $171.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
143658300 CARNIVAL CORP | 1.14% | $30.54 | $25.88 | -15.3% | $363.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
UBS UBS GROUP AG-REG | 1.13% | $39.53 | $48.13 | +21.8% | $439.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
UNH UNITEDHEALTH GROUP INC | 1.05% | $330.11 | $367.08 | +11.2% | $439.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BMRN BIOMARIN PHARMACEUTICAL INC | 0.95% | $77.79 | $60.00 | -22.9% | $362.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
SAIA SAIA INC | 0.94% | $284.19 | $333.74 | +17.4% | $363.3M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TIC TIC SOLUTIONS INC | 0.92% | $11.12 | $8.32 | -25.2% | $285.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CB CHUBB LTD | 0.84% | $312.12 | $325.25 | +4.2% | $329.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PGR PROGRESSIVE CORP | 0.80% | $227.72 | $207.31 | -9.0% | $276M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
LII LENNOX INTERNATIONAL INC | 0.80% | $485.58 | $355.02 | -26.9% | $220.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TW TRADEWEB MARKETS INC-CLASS A | 0.79% | $107.54 | $100.84 | -6.2% | $279.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
MDLN MEDLINE INC-CL A | 0.78% | $42.00 | $34.70 | -17.4% | $241.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AON AON PLC-CLASS A | 0.73% | $356.58 | $276.77 | -22.4% | $216.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AJG ARTHUR J GALLAGHER & CO | 0.71% | $258.79 | $228.11 | -11.9% | $237.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BAC BANK OF AMERICA CORP | 0.66% | $40.79 | $54.43 | +33.4% | $244.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
BSX BOSTON SCIENTIFIC CORP | 0.64% | $92.32 | $43.65 | -52.7% | $109.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
DLR DIGITAL REALTY TRUST INC | 0.62% | $154.71 | $175.53 | +13.5% | $264.7M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
LOW LOWE'S COS INC | 0.58% | $241.16 | $184.29 | -23.6% | $168.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
FIG FIGMA INC-CL A | 0.57% | $37.37 | $21.02 | -43.8% | $120.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ITUB ITAU UNIBANCO H-SPON PRF ADR | 0.54% | $7.16 | $8.53 | +19.1% | $242.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
AS AMER SPORTS INC | 0.48% | $32.74 | $27.29 | -16.6% | $131.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
RAL RALLIANT CORP | 0.43% | $48.49 | $69.17 | +42.6% | $218.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
RIOT RIOT PLATFORMS INC | 0.42% | $12.67 | $20.15 | +59.0% | $250.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
NAMS NEWAMSTERDAM PHARMA CO NV | 0.39% | $10.87 | $24.32 | +123.7% | $102.2M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ROIV ROIVANT SCIENCES LTD | 0.37% | $10.08 | $36.57 | +262.8% | $235.6M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
IQV IQVIA HOLDINGS INC | 0.37% | $225.41 | $268.85 | +19.3% | $166.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
SION SIONNA THERAPEUTICS INC | 0.35% | $10.98 | $5.26 | -52.1% | $16.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
INBX INHIBRX BIOSCIENCES INC | 0.30% | $14.17 | $100.08 | +606.3% | $143.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PHVS PHARVARIS NV | 0.27% | $18.21 | $31.72 | +74.2% | $115.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
CSGP COSTAR GROUP INC | 0.26% | $80.40 | $27.40 | -65.9% | $39.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
WST WEST PHARMACEUTICAL SERVICES | 0.22% | $275.14 | $370.76 | +34.8% | $109.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ORKA ORUKA THERAPEUTICS INC | 0.21% | $19.23 | $83.29 | +333.1% | $222.1M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
LAB STANDARD BIOTOOLS INC | 0.20% | $2.71 | $0.74 | -72.7% | $43.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
MASI MASIMO CORP | 0.18% | $162.33 | $177.87 | +9.6% | $91.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
ORIC ORIC PHARMACEUTICALS INC | 0.14% | $8.80 | $13.47 | +53.1% | $88.5M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
TRVI TREVI THERAPEUTICS INC | 0.11% | $6.86 | $14.32 | +108.7% | $45.8M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
DNA GINKGO BIOWORKS HOLDINGS INC | 0.08% | $8.15 | $12.83 | +57.4% | $45.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
PEPG PEPGEN INC | 0.06% | $6.88 | $2.42 | -64.8% | $8.4M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
75120L100 RALLYBIO CORP | 0.01% | — | $0.69 | — | $2.9M |
Quarter-end priceAvg. cost (est.)BoughtSold | |||||
Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price.
SEC filings for Q4 2025
- 13F-HR 0001103804-26-000002 · accepted Feb 17, 2026, 21:59 UTC